A Phase 2b Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Active Non-segmental Vitiligo Subjects
Public ClinicalTrials.gov record NCT03715829. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A PHASE 2B RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, DOSE-RANGING STUDY TO EVALUATE THE EFFICACY AND SAFETY PROFILE OF PF-06651600 WITH A PARTIALLY BLINDED EXTENSION PERIOD TO EVALUATE THE EFFICACY AND SAFETY OF PF-06651600 AND PF-06700841 IN SUBJECTS WITH ACTIVE NON-SEGMENTAL VITILIGO
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase 2b, randomized, double blind, parallel group, multicenter study with an extension period. The study will have a maximum duration of approximately 60 weeks. This includes an up to 4 weeks Screening Period, a 24 week dose ranging period, an up to 24 week extension period and a 8 week Follow up Period.
Study identification
- NCT ID
- NCT03715829
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 366 participants
Conditions and interventions
Conditions
Interventions
- PF-06651600 Drug
- placebo Drug
- PF06700841 Drug
- narrow-band UVB phototherapy Device
Drug · Device
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 26, 2018 (Actual)
- Primary completion
- Feb 5, 2021 (Actual)
- Completion
- Feb 5, 2021 (Actual)
- Last update posted
- Mar 25, 2022
2018 – 2021
United States locations
- U.S. sites
- 40
- U.S. states
- 15
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Marvel Research, LLC | Huntington Beach | California | 92647 | — |
| University of California, Irvine, Dermatology Clinical Research Center | Irvine | California | 92697 | — |
| Vitiligo and Pigmentation Institute Of Southern California | Los Angeles | California | 90036 | — |
| Dermatology Specialist, Inc. | Murrieta | California | 92562 | — |
| Dermatology Specialists, Inc. | Oceanside | California | 92056 | — |
| UC Davis Health | Sacramento | California | 95816 | — |
| Brookside Dermatology Associates | Bridgeport | Connecticut | 06606 | — |
| New England Research Associates, LLC | Bridgeport | Connecticut | 06606 | — |
| New Horizon Research Center | Miami | Florida | 33165 | — |
| Park Avenue Dermatology | Orange Park | Florida | 32073 | — |
| ForCare Clinical Research | Tampa | Florida | 33613 | — |
| Advanced Skin and MOHS Surgery Center, c/o TrialSpark, Inc. | Chicago | Illinois | 60657 | — |
| Chevy Chase Dermatology Center (TrialSpark, Inc.) | Chevy Chase | Maryland | 20815 | — |
| TrialSpark - Samantha Toerge, MD | Chevy Chase | Maryland | 20815 | — |
| TrialSpark - Ronald Shore, MD | Rockville | Maryland | 20852 | — |
| Tobias & Battite, Inc. | Boston | Massachusetts | 02111 | — |
| Tufts Medical Center | Boston | Massachusetts | 02111 | — |
| UMass Memorial Medical Center, Hahnemann Campus | Worcester | Massachusetts | 01605 | — |
| Investigational Drug Service Pharmacy | Worcester | Massachusetts | 01655 | — |
| UMass Memorial Medical Center Ear Nose and Throat | Worcester | Massachusetts | 01655 | — |
| University of Massachusetts Medical School | Worcester | Massachusetts | 01655 | — |
| Henry Ford Hospital Department of Dermatology | Detroit | Michigan | 48202 | — |
| University of Minnesota Department of Dermatology | Minneapolis | Minnesota | 55455 | — |
| The Dermatology Group, P.C. | Verona | New Jersey | 07044 | — |
| Icahn School of Medicine at Mount Sinai | New York | New York | 10003 | — |
| Upper West Side Dermatology c/o TrialSpark, Inc | New York | New York | 10023 | — |
| MDCS: Medical Dermatology & Cosmetic Surgery (TrialSpark, Inc.) | New York | New York | 10065 | — |
| South Nassau Dermatology | Oceanside | New York | 11572 | — |
| TrialSpark, Inc. - Russell W. Cohen, MD | Oceanside | New York | 11572 | — |
| PMG Research of Wilmington, LLC | Wilmington | North Carolina | 28411 | — |
| Remington-Davis, Inc. Clinical Research | Columbus | Ohio | 43215 | — |
| ForeFront Dermatology | Columbus | Ohio | 43220 | — |
| Vital Prospects Clinical Research Institute, PC | Tulsa | Oklahoma | 74136 | — |
| University Physicians Group | Austin | Texas | 78701 | — |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390-9191 | — |
| Pickens Academic Tower | Houston | Texas | 77030 | — |
| The University of Texas Health Science Center at Houston | Houston | Texas | 77030 | — |
| The University of Texas MD Anderson Cancer Center | Houston | Texas | 77030 | — |
| Virginia Clinical Research, Inc | Norfolk | Virginia | 23502 | — |
| Tamjidi Skin Institute (TrialSpark, Inc.) | Vienna | Virginia | 22182 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 52 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03715829, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 25, 2022 · Synced Oct 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03715829 live on ClinicalTrials.gov.